These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 36336884)

  • 1. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
    Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
    J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
    Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
    Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
    Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
    Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
    Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
    Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
    Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
    Front Immunol; 2021; 12():769204. PubMed ID: 34880865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alteration of N6-methyladenosine (m6A) modification at the transcriptome-wide level in response of heat stress in bovine mammary epithelial cells.
    Qi Y; Zhang Y; Zhang J; Wang J; Li Q
    BMC Genomics; 2022 Dec; 23(1):829. PubMed ID: 36517742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
    Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
    Ren S; Xiao Y; Yang L; Hu Y
    Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers.
    Ramasamy D; Thippannah M; Maharajan HRP; Balaiah M; Seshadri RA; Kodous AS; Herceg Z; Mehta A; Rao AKDM; Mani S
    Mol Biol Rep; 2024 Feb; 51(1):299. PubMed ID: 38345740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
    Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
    Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs.
    Steponaitis G; Stakaitis R; Valiulyte I; Krusnauskas R; Dragunaite R; Urbanavičiūtė R; Tamasauskas A; Skiriute D
    Sci Rep; 2022 Mar; 12(1):5431. PubMed ID: 35361860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
    Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
    Yin L; Ma C; Hou S; Ma X
    Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.